PubMed · 8918822
Quantification of Bcr-Abl transcripts in chronic myelogenous leukemia (CML) using standardized, internally controlled, competitive differential PCR (CD-PCR).
Abstract
The quantification of Bcr-Abl transcript numbers in chronic myelogenous leukemia (CML) patients described here uses simultaneous competitive PCR amplification of the target gene (Bcr-Abl) and a reference gene (porphobilinogen deaminase; Pbgd) together with a single composite competitor molecule for both targets based on heterologous sequences. Using this technique, Bcr-Abl transcript numbers could be reproducibly determined even in clinical samples known to harbour poor quality RNA.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
S Nagel, M Schmidt, C Thiede, D Huhn, A Neubauer. 1996-10-15. Quantification of Bcr-Abl transcripts in chronic myelogenous leukemia (CML) using standardized, internally controlled, competitive differential PCR (CD-PCR).. https://doi.org/10.1093/nar%2F24.20.4102
Cite the original work for its findings. Save a collection to share your selection of sources.